Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)

v3.23.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Common stock, beginning balance (in shares) at Dec. 31, 2021   604,174,329      
Beginning balance at Dec. 31, 2021 $ 1,316,759 $ 60 $ 1,793,431 $ (476,610) $ (122)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (62,319)     (62,319)  
Stock-based compensation 12,088   12,088    
Issuance of common stock upon exercise of stock options (in shares)   823,524      
Issuance of common stock upon exercise of stock options 428   428    
Issuance of common stock upon release of restricted stock units (in shares)   851,557      
Vesting of early exercised stock options and common stock issued in private placement 121   121    
Shares withheld related to net share settlement (in shares)   (13,041)      
Shares withheld related to net share settlement (85)   (85)    
Other comprehensive income (loss) (2,558)       (2,558)
Common stock, ending balance (in shares) at Mar. 31, 2022   605,836,369      
Ending balance at Mar. 31, 2022 1,264,434 $ 60 1,805,983 (538,929) (2,680)
Common stock, beginning balance (in shares) at Dec. 31, 2021   604,174,329      
Beginning balance at Dec. 31, 2021 1,316,759 $ 60 1,793,431 (476,610) (122)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (111,893)        
Common stock, ending balance (in shares) at Jun. 30, 2022   607,188,444      
Ending balance at Jun. 30, 2022 1,228,662 $ 60 1,822,235 (588,503) (5,130)
Common stock, beginning balance (in shares) at Mar. 31, 2022   605,836,369      
Beginning balance at Mar. 31, 2022 1,264,434 $ 60 1,805,983 (538,929) (2,680)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (49,574)     (49,574)  
Stock-based compensation 15,869   15,869    
Issuance of common stock upon exercise of stock options (in shares)   559,552      
Issuance of common stock upon exercise of stock options 318   318    
Issuance of common stock upon release of restricted stock units (in shares)   792,523      
Vesting of early exercised stock options and common stock issued in private placement 65   65    
Other comprehensive income (loss) (2,450)       (2,450)
Common stock, ending balance (in shares) at Jun. 30, 2022   607,188,444      
Ending balance at Jun. 30, 2022 $ 1,228,662 $ 60 1,822,235 (588,503) (5,130)
Common stock, beginning balance (in shares) at Dec. 31, 2022 622,602,815 622,602,815      
Beginning balance at Dec. 31, 2022 $ 1,164,741 $ 61 1,908,179 (734,653) (8,846)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (113,393)     (113,393)  
Stock-based compensation 14,157   14,157    
Issuance of common stock upon exercise of stock options (in shares)   945,803      
Issuance of common stock upon exercise of stock options 614   614    
Issuance of common stock upon release of restricted stock units (in shares)   5,836,813      
Issuance of common stock in private placement (in shares)   137,174      
Vesting of early exercised stock options and common stock issued in private placement 104   104    
Other comprehensive income (loss) 3,272       3,272
Common stock, ending balance (in shares) at Mar. 31, 2023   629,522,605      
Ending balance at Mar. 31, 2023 $ 1,069,495 $ 61 1,923,054 (848,046) (5,574)
Common stock, beginning balance (in shares) at Dec. 31, 2022 622,602,815 622,602,815      
Beginning balance at Dec. 31, 2022 $ 1,164,741 $ 61 1,908,179 (734,653) (8,846)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (399,472)        
Common stock, ending balance (in shares) at Jun. 30, 2023 692,560,949 692,560,949      
Ending balance at Jun. 30, 2023 $ 1,084,552 $ 67 2,223,049 (1,134,125) (4,439)
Common stock, beginning balance (in shares) at Mar. 31, 2023   629,522,605      
Beginning balance at Mar. 31, 2023 1,069,495 $ 61 1,923,054 (848,046) (5,574)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (286,079)     (286,079)  
Stock-based compensation 15,232   15,232    
Issuance of common stock upon exercise of stock options (in shares)   914,077      
Issuance of common stock upon exercise of stock options 679   679    
Issuance of common stock upon release of restricted stock units (in shares)   2,053,991      
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   1,047,001      
Issuance of common stock under the Employee Stock Purchase Plan 3,801   3,801    
Issuance of common stock in private placement (in shares)   59,023,275      
Issuance of common stock in private placement 280,196 $ 6 280,190    
Vesting of early exercised stock options and common stock issued in private placement 93   93    
Other comprehensive income (loss) $ 1,135       1,135
Common stock, ending balance (in shares) at Jun. 30, 2023 692,560,949 692,560,949      
Ending balance at Jun. 30, 2023 $ 1,084,552 $ 67 $ 2,223,049 $ (1,134,125) $ (4,439)